Skip to main content

Cronos Grows its International Footprint in Switzerland

Written by Customer Service on . Posted in Public Companies.

TORONTO, July 02, 2025 (GLOBE NEWSWIRE) — Cronos Group Inc. (NASDAQ: CRON) (TSX: CRON) (“Cronos” or the “Company”) announced today that it is expanding distribution with its PEACE NATURALS® medical cannabis brand in the Swiss market through its partnership with Dascoli Pharma AG (“Dascoli”), a Swiss-based company specializing in the supply and distribution of medical cannabis and healthcare training.

“We are excited to partner with Dascoli to bring high-quality medical cannabis to Swiss patients,” said Mike Gorenstein, Chairman, President and CEO, Cronos. “This partnership aligns with our mission to provide borderless cannabis products to European medical markets. Expanding our presence in Europe is an important area of focus for Cronos’ growth, and through this collaboration, we will leverage Dascoli’s strong local presence to better serve the needs of patients.”

Under the agreement, Cronos will supply PEACE NATURALS®-branded cannabis flower to Dascoli for distribution across its established medical network in Switzerland. This strategic collaboration marks another step in Cronos’ international growth strategy and strengthens its presence in key emerging medical cannabis markets.

The following PEACE NATURALS® flower will be available:

  • GMO Cookies
  • Space Cake
  • Atomic Sour Grapefruit
  • Sonic Lemon Fuel
  • Wedding Cake

PEACE NATURALS® medical cannabis products also recently launched in Australia and Malta. The brand is now available for patients in Australia, Canada, Germany, Israel, Malta, Switzerland and the UK.

About Cronos Group Inc.
Cronos is an innovative global cannabinoid company committed to building disruptive intellectual property by advancing cannabis research, technology and product development. With a passion to responsibly elevate the consumer experience, Cronos is building an iconic brand portfolio. Cronos’ diverse international brand portfolio includes Spinach®, PEACE NATURALS® and Lord Jones®. For more information about Cronos and its brands, please visit: thecronosgroup.com.

About Dascoli Pharma AG
Dascoli is a Swiss-based pharmaceutical firm focused on medical cannabis manufacturing & distribution across wholesale and retail channels. Headquartered in Zurich, it supplies compliant cannabinoid therapies to patients, pharmacies and clinics. Dascoli is a leading cannabinoid retailer with next-day home-delivery nationwide for patients. For more information about Dascoli, please visit: www.dascoli-pharma.ch

Forward-looking Statements  
This press release may contain information that may constitute “forward-looking information” or “forward-looking statements” within the meaning of applicable Canadian and U.S. securities laws and court decisions (collectively, “Forward-looking Statements”). All information contained herein that is not clearly historical in nature may constitute Forward-looking Statements. In some cases, Forward-looking Statements can be identified by the use of forward-looking terminology such as “may”, “will”, “expect”, “plan”, “anticipate”, “intend”, “potential”, “estimate”, “believe” or the negative of these terms, or other similar expressions intended to identify Forward-looking Statements. Some of the Forward-looking Statements contained in this press release include statements about the expansion of the PEACE NATURALS® brand in the Swiss market, including through its partnership with Dascoli; the launch of new products within the Swiss market; the Company’s growth and growth strategy within international markets; and the Company’s intention to build an international iconic brand portfolio and develop disruptive intellectual property by advancing cannabis research, technology and product development. Forward-looking Statements are necessarily based upon a number of estimates and assumptions that, while considered reasonable by management, are inherently subject to significant business, economic and competitive risks. Financial results, performance or achievements expressed or implied by those Forward-looking Statements and the Forward-looking Statements are not guarantees of future performance. A discussion of some of the material risks applicable to the Company can be found in the Company’s Annual Report on Form 10-K for the year ended December 31, 2024 and the Company’s Quarterly Report on Form 10-Q for the quarter ended March 31, 2025, each of which has been filed on SEDAR+ and EDGAR and can be accessed at www.sedarplus.ca and www.sec.gov/edgar, respectively. Any Forward-looking Statement included in this press release is made as of the date of this press release and, except as required by law, Cronos disclaims any obligation to update or revise any Forward-looking Statement. Readers are cautioned not to put undue reliance on any Forward-looking Statement. 

Media Relations Contact:
Emily Whalen
Communications
Tel: (416) 504-0004
media.relations@thecronosgroup.com

Disclaimer & Cookie Notice

Welcome to GOLDEA services for Professionals

Before you continue, please confirm the following:

Professional advisers only

I am a professional adviser and would like to visit the GOLDEA CAPITAL for Professionals website.

Important Notice for Investors:

The services and products offered by Goldalea Capital Ltd. are intended exclusively for professional market participants as defined by applicable laws and regulations. This typically includes institutional investors, qualified investors, and high-net-worth individuals who have sufficient knowledge, experience, resources, and independence to assess the risks of trading on their own.

No Investment Advice:

The information, analyses, and market data provided are for general information purposes only and do not constitute individual investment advice. They should not be construed as a basis for investment decisions and do not take into account the specific investment objectives, financial situation, or individual needs of any recipient.

High Risks:

Trading in financial instruments is associated with significant risks and may result in the complete loss of the invested capital. Goldalea Capital Ltd. accepts no liability for losses incurred as a result of the use of the information provided or the execution of transactions.

Sole Responsibility:

The decision to invest or not to invest is solely the responsibility of the investor. Investors should obtain comprehensive information about the risks involved before making any investment decision and, if necessary, seek independent advice.

No Guarantees:

Goldalea Capital Ltd. makes no warranties or representations as to the accuracy, completeness, or timeliness of the information provided. Markets are subject to constant change, and past performance is not a reliable indicator of future results.

Regional Restrictions:

The services offered by Goldalea Capital Ltd. may not be available to all persons or in all countries. It is the responsibility of the investor to ensure that they are authorized to use the services offered.

Please note: This disclaimer is for general information purposes only and does not replace individual legal or tax advice.